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ACCEPTED VERSION 
Very Late Onset Schizophrenia-like Psychosis (VLOSLP); A Clinical Update for Nurses 
Psychosis symptoms (delusions and hallucinations) are multifactorial in origin and, in later life occur in the 
context of schizophrenia, delirium, dementia, delusional and schizophrenia-like disorders, mood disorders, 
and alcohol or substance abuse.  In this paper, we provide a clinical overview of very late (after 60yrs) onset 
schizophrenia-like psychosis (VLOSLP); summarising the literature on treatment options and reflecting on 
the role of the MHN.   
Preoccupying multi-modal hallucinations and delusions and a lack of insight are characteristic features in 
VLOSLP and it is not uncommon for those referred to mental health services to refuse an initial assessment, 
and to decline or discontinue treatment. Early intervention and outreach services are an integral part of 
service infrastructure for younger people experiencing schizophrenia but are generally not available for older 
adults with VLOSLP.  Increased awareness of the clinical presentation, key features and evidence-based 
treatment options will assist MHNs to confidently recognise this often under-diagnosed disorder and to 
adopt a more assertive role in terms of engagement and follow up.  
The current consensus is that VLOSLP symptoms are best managed with low dosage atypical antipsychotic 
medication, but the very-late onset patient group have greater susceptibility to therapeutic and adverse 
effects of antipsychotic drugs compared to those with earlier illness onset.  Such issues increase the 
likelihood of non-compliance and disengagement with services. The role of the frontline MHN is pertinent, 
particularly in terms of developing rapport, facilitating engagement, discussing medication, supporting 
compliance and competently monitoring emergent side effects.  Pragmatic research involving people with 
VLOSLP is required to increase the evidence base for treatment and improve outcomes of care. 
Keywords: Very Late Onset Schizophrenia-like Psychosis (VLOSLP), mental health nursing, older adults, 
therapeutic relationship, engagement.   
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It has long been acknowledged that psychotic illness can lead to alienation, discrimination and isolation 
(Burke & Shome 1998), and that older people with psychosis represent one of the most disenfranchised 
groups in relation to health care (Mitford et al 2010).  In the Older Adult mental health setting nurses 
encounter two main groups with a schizophrenia diagnosis – people with early-onset schizophrenia (EOS) 
who have grown old and those who experience the onset of psychosis in later life, either as a late-onset 
(over 40 years) schizophrenia (LOS, or a very late-onset (after 60 years) schizophrenia-like psychosis 
(VLOSLP).  
Older people with schizophrenia have been somewhat neglected historically by the scientific research 
community (Folsom 2006, Cohen et al 2008,) and there is a significant gap between the high prevalence of 
psychotic disorders in the elderly and the availability of evidenced-based treatments (Reinhardt &Cohen 
2015).  This leaves health care systems ill prepared to deal with the predicted substantial growth in the older 
population (Cohen, Meesters & Zhao 2015).  
Drawing on the published literature and on the authors’ clinical and research experience, the paper reflects 
on VLOSLP from a person-centered, biopsychopharmosocial mental nursing perspective (Clarke and Clarke 
2014); describing clinical presentation and treatment interventions.    A search of PubMed and CINAHL using 
‘very late -onset schizophrenia –like psychosis’ and a range of related terms combined with ‘(mental 
health/psychiatric) nursing revealed very little attention specifically relating to mental health nursing care of 
this patient group, although information is available in relation to generically supporting older people 
experiencing psychosis and /or schizophrenia. 
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Diagnostic issues. 
VLOSLP is described as ‘schizophrenia-like’ as it typically presents with positive symptoms (prominent 
delusions and multimodal hallucinations), in the absence of formal thought disorder and negative symptoms 
that are typically seen in EOS, but with greater sensory disturbance (Howard et al, 2000; Kohler et al, 2007).  
In contrast to EOS, VLOSLP occurs more commonly in women (after adjusting for gender differences in 
mortality), and is less associated with familial occurrences, or childhood trauma (Reeves & Brister 2008).   
Those with VLOSLP typically describe distressing delusional beliefs and hallucinations, often of a persecutory 
nature, which have a profound impact on the person’s daily life and wellbeing.  Also characteristic of VLOSLP 
are ‘partition’ delusions which involves belief that structures which normally act as barriers to movement, 
sight and sound (for example ‘walls, floors, ceilings, and doors’)(Howard et al, 1992) become permeable, 
allowing a person to be observed, harmed, stolen from and even sexually assaulted.   
The exact onset of VLOSLP can be hard to establish. Zarit and Zarit (2012) suggest a two-stage process, 
characterised by initial suspicion, irritability and ideas of reference, which then erupts into more dramatic 
visual and auditory hallucinations and delusional interpretation of life events. Cross-sectional studies have 
found that social isolation (Island et al 1994, Almeida et al 1995, Hasset 1999) and sensory deficits are 
common (Hassett 1997, Eissa et al 2013) in VLOSLP, although no direct causal link has been established, and 
it is equally possible that the tendency to isolate oneself or failure to acknowledge or correct sensory deficits 
are part of a prodromal phase.  The aetiological contribution of ‘neurodegeneration’ or ‘organic’ factors to 
VLOSLP remains unclear (Barak et al 2002,  Brodaty et al 2003, Palmer et al 2001, Jones et al 2005), and 
increased first service contact rates in older adults from ethnic minority groups, suggests that psychosocial 
stressors may be equally important (Reeves et al, 2001; Mitter 2005).   Historically the nosology of late-onset 
and very late-onset schizophrenia like psychosis (VLOSLP) has been contentious (Sharma et al 2014). The 
long history of differing opinions about age of onset, confusion about diagnostic criteria and challenges of 
differential diagnosis have resulted in varied and often conflicting findings (Pearman & Batra 2015).  
    
4 
VLOSLP for resubmission July2017 
 
Consensus on diagnosis, nomenclature, treatment guidelines and future research guidelines was only 
reached in 2000, following an International Late-Onset Schizophrenia Group Consensus group meeting 
(Howard et al 2000), in which VLOSLP was defined as a ‘schizophrenia-like’ psychosis with onset after 60 
years, which cannot be attributed either to a primary affective disorder or focal or progressive structural 
brain abnormalities (see Box 1).    
VLOSLP is estimated to affect around 34,000 of the UK population with 2,800 new service contacts per year 
(Howard et al 2000). The prevalence of late life schizophrenia at the age of 95 is 2.4% and the number of 
people with this disorder is likely to increase (Royal College of Psychiatrists (R.C.Psych), 2012).  The Royal 
College of Psychiatrists (R.C.Psych) are trying to improve the recognition of schizophrenia in older people, 
pointing out that VLOSLP may be regarded as eccentricity or misdiagnosed as dementia (R.C.Psych 2012).  
Jeste, Blazer & First (2005) call for aging-appropriate diagnostic criteria for major disorders such as 
schizophrenia in later life in order to reduce the accuracy of epidemiological data, improve diagnosis and 
facilitate study of premorbid indicators, neurobiological underpinnings, prognosis and management.  
In VLOSLP a multi-modal treatment approach involving individual care planning, judicious prescribing of 
antipsychotic medication, psychological support, education, family and community resources is essential, 
but is not yet supported by a robust evidence base (Reinhardt & Cohen 2015).     Those who do access services 
are not necessarily served well.  For example, a recent UK audit found that 54% of people assessed and 
diagnosed with VLOSLP failed to engage with services or were lost to follow up, with only 28% taking 
antipsychotic drug treatment at the point of discharge (Lam et al 2016).   
Presentation (see Box 2)  
People with VLOSLP typically lack insight into their illness and, as a result, their presentation to mental health 
services is largely initiated by others (GP, neighbours, family, emergency services) and is often an indication 
that the experience is leading to increased distress, disturbing feelings, thoughts and behaviours (Byrne 
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2007).   People experiencing symptoms of VLOSLP can feel frightened, distressed, outraged or simply 
overwhelmed by their experiences and referral to mental health services can provoke uncertainty, hostility 
and fear.   Subtlety, patience and tenacity may be required before a person agrees to an initial assessment, 
and psychotic symptoms can hinder communication, provoke frustration and lead to a lack of connection for 
both parties.  Our experience with this patient group has taught us that sufficient time needs to be invested 
in the engagement process and several visits or attempts to visit are required before seemingly therapeutic 
progress is achieved.   People experiencing persecutory beliefs and hallucinations can become defensive or 
antagonistic and frustrated when encountering people who disbelieve them. A non-judgemental approach 
and active listening to complaints about neighbours’ intrusions can diffuse the anger and distress associated 
with delusional beliefs, and decrease the likelihood provoking a confrontation or repeated calls to 
emergency services (Howard 1999). Relationship building and engagement are integral aspects of a dynamic 
process associated with, but not limited to, the initial stages of the nurse/patient relationship (Ryrie & 
Norman 2013).  In patients with VLOSLP, who represent the most difficult to engage group of older people 
with psychosis, developing a therapeutic alliance is particularly challenging (Lam et al 2016).    
The therapeutic relationship that is so fundamental to mental health nursing requires a complex interplay of 
specialised skills that need to be continually developed and refined: conveying understanding and empathy; 
accepting individuality; providing support; being there/being available; being genuine; promoting equality; 
demonstrating respect; maintaining clear boundaries and having self-awareness (Dziopa & Ahern 2008). 
Such skills and practice should not be under-estimated or taken for granted.  Quality therapeutic 
relationships improve outcome in terms of mediating care such as increased treatment adherence but also 
in terms of direct benefit of the relationship itself (Priebe & McCabe 2008).  MHNs need to take an assertive 
role in developing best-practice care for older adults living with VLOSLP and ensure that sufficient time and 
effort is directed towards the engagement process. 
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Co-morbid medical problems, particularly cardiovascular and cerebrovascular disease, are common in 
elderly people, and this has both diagnostic and prognostic implications (Kennedy & Frazier 1999, Auslander, 
Perry, & Jeste, 2002).  Talaslahti et al (2015) found higher standard mortality rates in VLOSLP patients 
compared to those with EOS; which was largely accounted for by ‘physical comorbidities’ and ‘accidents’ in 
those with VLOSLP.   MHNs should adopt an integrated approach whereby physical and mental health issues 
are regarded as equally important.  Physical health assessment and care needs to be acceptable to the 
patient and is likely to be governed by the rapport and level of trust established.  The rationale for tests and 
investigation need to be fully explained and consent given (or declined).   
Clinical management of older patients with a new onset disorder (Lubman and Castle, 2002) includes; taking 
a comprehensive history (including medications), physical examination (including neurological), blood tests, 
structural imaging and cognitive screening. Where possible a collateral history should be obtained from 
family, GP or other available source. Before a diagnosis of VLOSLP is made the differential diagnoses must 
be considered and excluded or monitored (Box 4).   In old age psychiatry, treatment is guided by the principle 
of minimum intervention, aiming to identify and reverse components of the illness where possible, and 
reduce the secondary impact of delusional symptoms on a person’s ability to function (Zarit & Zarit 2012).    
Risk Assessment 
Elderly people with psychosis represent are a highly vulnerable group.  Florid symptoms may affect capacity 
and lead them to make unsafe decisions or engage in behaviours that can threaten their personal wellbeing 
or endanger others (Talaslahti et al, 2014).  The experience of persecutory delusional beliefs can lead people 
to isolate themselves, adopt extreme measures to protect themselves (multiple locks, weapons) or 
contemplate suicide.  Depressive symptoms are frequent in older people with schizophrenia and there is an 
association of depressive symptoms and positive symptoms (Zisook et al 1999) which need consideration 
when assessing (suicide) risk regardless of the patients age (Meesters 2014).   Nutritional status may be 
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compromised if the person is experiencing preoccupying symptoms and if there are fears that food and drink 
has been tampered with. The MHN should assess for physical signs of illness or self-neglect and/or skin 
problems (in particular when there are potential risks of the person developing pressure ulcers).  Ideas of 
persecution and a perception of a hostile social environment increase anxiety and stress, and can disrupt 
family and social relationship, as delusional beliefs are often directed towards those in close personal or 
physical proximity (Gwyther & Steffens 2007).   Social isolation can be identified as a risk factor as can an 
over stimulating social environment.   
The comprehensive risk assessment needs to be able to identify, record, share and respond to abuse, harm 
and neglect and MHNs have a pivotal role to assess the safety of the home environment and work in close 
communication with the multidisciplinary team. Many people are best cared for at home but those who are 
vulnerable and at risk may require admission for assessment and/or treatment. Based on their case register 
study of older people with VSLOSLP.  Talaslahti et al (2016) recommend long term and comprehensive 
outpatient care to reduce the need for psychiatric hospitalisation with observations of physical illness to 
reduce the risk of premature long-term residential care.   
Additional barriers  
Where VLOSLP symptoms arise in the context of sensory impairment, remedial action should be taken.  In 
our experience, it is not unusual for those presenting with VLOSLP to have neglected routine health visits for 
example to the optician and audiologist (Howard et al, 2000).  Delusional persecutory beliefs may provoke 
the person to stop using the phone, reduce use of radio/ TV or computer so that channels of communication 
from the social world are reduced. Being a member of a migrant group is a risk factor for VLOSP (Reeves et 
al 2001; Mitter et al, 2005) and language may act as an additional barrier to communication. Awareness of 
cultural and ethnic differences in explanatory models of illness, idioms of distress, treatment expectations 
and adherence is crucial (NICE 2014). Key to this process is striving to understand the cultural context of a 
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person’s experiences and their interpretation (Reeves et al, 2003), respecting diversity and avoiding a ‘one 
size fits all’ approach to the therapeutic alliance (Priebe & McCabe 2008).   
Managing care 
Essential MHN responsibilities include liaison and maintaining clear channels of communication between the 
patient (and carers), health professionals and other agencies involved, accurate reporting and recording of 
information and care-planning. The specific role of the MHN will be guided in part by their skill level and 
competencies. Working with patients experiencing psychotic symptoms can be challenging and 
organisational structures need to include adequate clinical training and supervision. The National Institute 
for Health and Care Excellence (NICE) recommendations for schizophrenia and psychosis, whilst not 
specifically targeted at people with schizophrenia over the age of 60 years, have relevance for nurses working 
with older adults (NICE [CG178] 2014).   
The MHN should work from the person’s perspective to clarify their concerns, understand what grounds 
their beliefs are held and how ideas have developed.   Willingness to listen with empathic response and 
acknowledgement of distress relating to psychotic experiences is required rather than challenging the e to 
the reality of them.  Non-judgemental active listening provides validity to the experience, allows emotional 
ventilation and signals genuine concern.   An approach to patients experiencing VLOSLP is usefully informed 
by the Cognitive Behavioral for psychosis (CBT-p) model which adopts a continuum approach to symptoms 
thus placing them in a less stigmatizing context and allowing movement on this continuum (Sivec & 
Montesamo 2012a).  Particular strategies used in CBT-p designed to develop of the therapeutic alliance 
(regarded as critically important), to formulate shared understanding and promote coping with symptoms 
(Sivec & Montesano 2012b) would appear relevant.  
MNH needs to be confident in their theoretical knowledge of psychopathology and ability to elicit and 
monitor symptoms and associated risks. Assessment and evaluation of symptoms (and treatment response) 
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can be enhanced through the use of validated rating scales, such as the Brief Psychiatric Rating Scale (BPRS) 
(Overall & Gorham 1962); which has been used in clinical trials of antipsychotic treatment in VLOSLP (Psarros 
et al 2009, Howard et al submitted paper 2017).  Clinicians can be trained in less than a day to use the BPRS 
reliably and its use with this patient group is appropriate; with Hostility, Suspiciousness, Hallucinations, 
Unusual Thought Content, Tension, and Uncooperativeness items being particularly relevant to VLOSLP 
(Page 9 ATLAS Protocol Version 2 Dated 05/05/2015). 
Pharmacological interventions and monitoring   
In a recovery-based MH service, medication is one strand of recovery support that can be offered (Slade & 
Davidson 2011).  The nurse’s role requires awareness and knowledge of the potential effects of ageing on 
how psychotropic drugs are metabolised and cleared from the body, and the nature and prevalence of 
potential adverse effects (Clibbens 2005). Informed choice is relevant and individual capacity for decisions 
about treatment should be assessed.  Discussing psychotropics can create tension within the nurse-patient 
relationship (Marland et al 2011) with most people being justifiably wary of antipsychotic medication and 
those experiencing paranoia additionally suspicious. The lack of insight that accompanies VSOSLP means that 
the patient is unlikely to accept that s(he) has a psychotic illness that could respond to treatment.  Individual 
attitudes about medication need to be explored using the persons own terminology with a clear rationale 
for why trying the medication has been proposed; for example, reducing anxiety levels, sleeping better, 
providing peace of mind and ability to cope.    MHN should not shy away from open discussion about 
antipsychotics; sharing current evidence, explaining dosage recommendations for older people and 
monitoring of treatment effects including possible side effects.  Conversations should not be hurried and the 
issue may ned to be revisited at a pace set by the patient; for example:   
    “Do you know why the doctor has asked you to try the medication?   (Listen and discuss) 
   “How do you feel about that” “What do you think of that suggestion?” (use genuine curiosity) 
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     “We know from research and our work with other people who are going through similar experiences as 
yourself, that sometimes as well as having someone to talk to, medication can help… it’s not always easy to 
explain but some people find that when they take a tablet like this (known as an antipsychotic) they feel 
more able to manage the situation they are in.” (discuss response).  
Those involved with discussions about medication experience less coercion and feelings of powerlessness 
(Freeman 2002); and increased adherence to medication in patients with schizophrenia is associated with a 
perceived stronger alliance between patient and clinician (Dolder et al 2002, McCabe et al 2012). 
Antipsychotic medication should be considered within a clearly defined treatment plan that weighs up the 
risk and benefits of the intervention (Chahine et al 2010). The underlying mechanisms of antipsychotic drug 
sensitivity in VLOSLP are not yet fully understood, as research in older people with schizophrenia rarely 
distinguishes between patients on the basis of age of illness onset. Furthermore, the focus of research is 
often directed towards those with dementia, who are at greatest risk of antipsychotic related morbidity and 
mortality (Reeves et al 2017). Decisions around dosage are often further complicated by concurrent medical 
problems and associated drug treatments (Chan, Lam, & Chen, (2011). ECG screening is recommended for 
people with significant cardiac risks and individual patient assessment should take account of co-morbid 
medical conditions or concomitant medications that might increase the risk of adverse drug effects (Reeves 
& Brister 2008, Chahine et al, 2010).  Assessment of renal and liver function is also recommended prior to 
starting antipsychotic therapy (Arbus et al 2011). 
Prescribing for people with VLOSLP is particular challenging, as they are exquisitely sensitive to antipsychotic 
drug side effects (Reeves et al 2002; Howard et al 2008), which increases the risk of non-compliance and 
subsequent disengagement (Lam et al, 2016). The general consensus (Howard et al, 2000, Alexopoulos 2004) 
is that doses as low as 20% of those prescribed to people with EOS (and 50% of those prescribed to people 
with LOS) can be sufficient to relieve symptoms and minimise side effects in VLOSLP. This has been recently 
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confirmed in a randomised, placebo-controlled trial, which 100mg/day amisulpride was effective and largely 
well tolerated in VLOSLP (Howard et al 2017 submitted paper), which argues for a more assertive approach 
to engagement and antipsychotic drug treatment  
Monitoring of symptoms and side effects (See Box *) 
Antipsychotic drug related side effects (falls, sedation, extrapyramidal side effects, postural hypotension) 
are greater following the use of first generation antipsychotics (haloperidol) in older people, and second- 
generation antipsychotics are thus preferred, particularly for those with VLOSLP who are at greater risk of 
EPSE than those with an earlier onset illness (Essali & Ali 2012). However, weight gain, diabetes and 
metabolic syndrome can be serious complications of antipsychotic therapy (in particular clozapine and 
olanzapine) and require careful monitoring (Chahine et al 2010).  Viligance is required when reviewing 
compliance and side effects. The MHN should record pulse and both lying and standing blood pressure and 
elicit any signs of dizziness, or postural drop. Patients with VLOSLP are second only to those with dementia 
in their sensitivity to EPSE (Reeves et al 2017) and MHNs should be confident in their ability to identify 
emergent EPSE, both by observation of gait, facial expression and salivation, and direct examination of the 
wrist and elbow to elicit rigidity. 
Other side effects of antipsychotic to be considered include; Xerostoma (dry mouth) which is associated with 
increased risk of dental disease and reduced quality of life (Kisely et al 2011; constipation and urinary 
retention associated with medication such as clozapine and olanzapine due to the drug’s higher 
anticholinergic properties (Chahine et al 2010); and unwanted drowsiness or sedation which can increase 
the falls risk.  The MHN should work collaboratively with the patient and with the medical team to establish 
the optimal effective and acceptable treatment. Ritchie et al (2010) found that older adults with 
schizophrenia who complied with antipsychotic therapy in the first 6moths had increased long term 
adherence rates, which supports the importance of engaging people in the early stage of treatment. 
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Medication management (of both psychiatric and physical health medicines) is an important component of 
health self-management for older adults with schizophrenia and nurses can encourage informed adherence 
through the use of open communication and routine patient education (including practical measures such 
as routine and structure, bubble packs and updated medication lists (Leutwyler et al 2013).  
Non-pharmacological interventions  
The MHN can promote activities that enhance self-esteem and develop coping skills from a positive stance, 
focussing on personal strengths and ability not just areas of need.  In the absence of controlled trial data, it 
is difficult to draw firm conclusions or to evaluate the potential contribution of the non-drug components of 
patient care, including engagement with members of the Community Mental Health Team and Social 
Services staff (Howard 2008).   Although the evidence base for effective non-pharmacological interventions 
for people with VLOSLP is yet to be established RCTs involving cognitive remediation therapy, CBT and social 
skills programmes carried out in LOS, have demonstrated improvement in relation to cognitive deficits, social 
relatedness, mood and psychosis (Cohen, Meesters and Zhao 2015) and psychological approaches in adjunct 
with antipsychotic medication have also been acknowledged as beneficial (Clare & Giblin 2008).  
Results of pilot studies such as Helping Older People Experience Success—Individually Tailored (HOPES–I) 
support the feasibility of and suggest potential benefits of an individually tailored living skills training 
program  with older people with serious mental illness including schizophrenia (though not specifically very 
late onset) (Pratt et al, 2017);  an exploratory study, which evaluated the cognitive aetiology of persecutory 
delusion formation and maintenance in VLOSLP, showed evidence of mentalizing errors but not the other 
cognitive biases described in EOS. The authors argued for the development of new cognitive models for 
psychotic symptoms, which could be used to guide psychological interventions (Moore et al 2006). 
Studies have shown that nurses and case managers with brief training can deliver Cognitive Behavioral 
techniques for psychosis (CBt-p) with positive effects to younger patients with schizophrenia spectrum 
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disorders (Sivec & Mentesano, 2012). Such approaches could be trialled and adapted for use with older 
people with VLOSLP as increasing the MHNs repertoire of skills to respond effectively to psychotic experience 
could be beneficial in terms of continuation of care. Such training would also inform a structured phased 
approach to delivering support: with attention to the engagement process (using strategies such as 
normalising and shared formulation  ( For process examples of clinical practice see, Sivec & Mentesano, 
2012) 
Caregiver support 
Caregivers of patients living with psychosis can face considerable difficulties including the challenge of 
dealing with a range of unusual or bizarre symptoms that can be hard to understand and cope with on an 
emotional and practical level (Kuipers, 2010). Long standing paranoia can lead to conflict and part of the 
MHN role is to support family members, to enable them to reframe and deal with such issues (Lubman & 
Castle, 2002). Alternatively, relatives may need help and support to create distance and ‘mental space’ 
between themselves and the person, to minimise negative interactions and/or reduce risk. The carers’ 
support plan should include psychoeducation, strategies for coping, and advice about how to respond to 
delusional beliefs, or ongoing hallucinations.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
Limited capacity for interpersonal relationships is noted in people experiencing VLOSLP (Hasset, 1999) and 
care packages should be aimed at promoting a social environment that is not over-stimulating or against the 
person’s wishes, whilst avoiding social isolation. Relationships may need to be re-appraised and re-
negotiated between the patient and caregivers (Kuipers, 2010).  
On-going support 
The MHN is required to work alongside the patient to develop an understanding of their illness experience, 
consider how ‘wellness’ can be achieved, and evaluate care received. A stress-vulnerability model can be 
used to help a person make sense of why a psychosis may have developed, and recognising stress triggers 
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may enable people to reduce the likelihood of relapse (Freeman 2002).  Although research on relapse 
prevention is almost entirely focused on those with an earlier onset of schizophrenia, it seems likely that 
those with VLOSLP would benefit from approaches that empower and respect the individual. Blanchard et 
al (2009) propose a re-integrative model for Old Age Psychiatry that enables the person to come to terms 
with loss, adapt and emerge with a new concept of self, sense of meaning and empowerment.   The MHN 
has a role to challenge assumption about disability, mental illness and older adults and be assertive in helping 
to develop interventions that recognize and foster personal development for older adults with schizophrenia 
(Sorrell and Collier 2011). Service pathways and the discharge process need to be planned and 
collaboratively discussed with the patient, GP and relevant agencies (including treatment summary, follow 
up advice, warning signs of relapse, crisis plan and future goals).   It is important that the person knows 
how to access help in the future and a low threshold for re-referral for patients with VSLOSLP should be 
considered.  Those who remain on anti-psychotic medication will require continued monitoring of 
symptoms, compliance and side effects. Without effective integrated community-based mental health 
services, older adults are unlikely to receive much needed treatment and it is important that nurses, 
alongside other health care professionals, researchers, and policy makers, step up to the challenge and 
continue to advocate for and develop an improved collaborative age adapted mental health care system 
that can address unmet need in this group (Sorrell 2016). 
Conclusion 
The consensus on management of VLOSLP is that atypical antipsychotic medication is the cornerstone of 
treatment, and advises physical screening, the use of very low doses, and ongoing safety monitoring. 
However, it is important to remember the therapeutic context that needs to be in place before such 
medications can be prescribed and monitored effectively.  The therapeutic relationship is fundamental.  
Gaining trust of people experiencing psychosis translates into really listening to their story, ‘getting inside 
their world’, acknowledging their beliefs and why they hold them (Freeman 2002). Building trust and 
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sustaining this relationship is a crucial part of the MHN role, and requires compassion and strong 
collaborative multi-professional team work. Medication is never a stand-alone treatment, rather it is an 
adjunct to good quality mental health care that integrates bio-psychosocial aspects of well-being. Much can 
potentially be achieved with non-pharmacological interventions for older people experiencing psychosis 
(Karim & Bryne 2005).  Outcomes for care need to be judged not only on the presence or absence on 
symptoms but on issues such as quality of life, subjective wellbeing and how the person is able to function 
socially (Vahia et al 2007).    
Research on schizophrenia has largely focussed on EOS (Kohler et al 2007, Collier & Sorrell 2011), and the 
literature on mental health nursing in older adults focuses on dementia and depression, with a relative 
absence of information on VLOSLP.  This discrepancy needs to be addressed in order to understand the 
antecedents, illness course, and successful management and intervention strategies (Hasset 1999, Reeves & 
Brister 2008). Older patients should not be denied either the therapeutic optimism, or the assertive 
treatment and early interventions that are available to younger patients with schizophrenia (Burke & Shome 
1998, Mitford et al 2010). MNHs have a responsibility to challenge ageism and negative attitudes towards 
older people with schizophrenia (Collier & Sorrell 2011).  MHNs play a pivotal role in engaging and supporting 
people with VLOSLP, formulating individualised care plans and working to increase resilience. Clinically 
meaningful randomised studies are needed to help guide clinicians in their management of elderly people 
with schizophrenia. On a broader level, nurses can endeavour to raise the profile of this highly vulnerable 
group, and collaborate with other professionals to optimise engagement and contribute to much needed 
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